Zolinza (vorinostat capsules – Merck) — Cigna
Classic Hodgkin Lymphoma
Initial criteria
- Patient age ≥ 18 years
- Patient has tried at least three systemic regimens
- Medication is used in combination with Keytruda (pembrolizumab intravenous infusion)
Approval duration
1 year